What's new at Łukasiewicz – PORT?
- Reading time: 3 min.
Prof. Bastian Hengerer, Director of the P4Health Center, talks about his vision for the center, translating scientific discoveries into solutions for patients, and management based on trust.
- Reading time: 5 min.
Glioblastoma is one of the most formidable challenges in modern oncology—a cancer that often evades both conventional treatments and advanced immunotherapies. In the SelCell project, scientists at the Łukasiewicz – PORT are exploring a new strategy based on gamma-delta T lymphocytes. Their goal is to understand why immune cells from some donors can destroy tumor cells far more effectively than those from others.
- Reading time: 3 min.
Dr. Valentina Mosienko from the University of Bristol will speak on June 11 about how stress affects brain function and the role glial cells may play in emotional regulation and the action of antidepressant drugs.
- Reading time: 3 min.
For decades, we viewed tumors as autonomous aggressors – isolated masses of mutated cells. Today, we know that picture is incomplete. Tumors send signals, form connections, and actively shape their surroundings.
- Reading time: 3 min.
On 1–2 June 2026, Brussels will host “From Ideas to Impact: Emerging Health Technologies in Action” – a two-day event dedicated to health innovation, international collaboration, and building project partnerships within European research and innovation initiatives.
- Reading time: 3 min.
Precision medicine is transforming diagnosis and treatment, requiring advanced molecular analysis, deep insight into disease mechanisms, and high-quality biological samples, making close collaboration between researchers, laboratories, and hospitals essential for implementing innovative therapies.
- Reading time: 3 min.
Disruptions in energy metabolism are increasingly linked to the development of neurodegenerative diseases. Research by Dr. Ismail Gbadamosi shows how TDP-43 and energy imbalance influence motor neuron vulnerability in ALS, opening the way to new therapeutic strategies.
- Reading time: 3 min.
A delegation of senior leadership from Łukasiewicz – PORT visited Dresden and Leipzig to strengthen collaboration with leading life sciences institutions in Saxony, focusing on biobanking, precision medicine, novel therapies, and cross-border R&D opportunities.
- Reading time: 3 min.
Leading scientists, clinicians, industry representatives, working at the intersection of oncology, neuroscience, and precision medicine will meet at Łukasiewicz – PORT on May 28–29, 2026.
- Reading time: 3 min.
Dr. Andrii Domanskyi, a neurobiologist with years of academic and industry experience, will discuss chronic pain research on April 16 at 2:00 PM in the Main Hall of Łukasiewicz – PORT.
- Events
- Events
